Pharmacy Practice News: As Losses Mount From 340B Cuts, Hospitals Cry Foul

“Late last year, 340B Health, an organization representing 1,300 hospitals participating in the federal discount 340B Drug Pricing Program, released a survey warning that impending deep cuts in Medicare Part B reimbursements for 340B drugs would greatly harm access to care for low-income and rural patients.

Now, more than six months after those cuts took effect on Jan. 1, the reality is sinking in. The $1.6 billion reduction in Outpatient Prospective Payment System (OPPS) reimbursements for 340B drugs has begun to challenge hospitals’ ability to maintain the expanded care services for vulnerable patient populations that the program’s savings afforded.”

Read more: https://bit.ly/2vSz4Im